Document is current
Any future updates will be listed below
-
Authors
Betschel, Stephen D.
Peter, Jonny
Lumry, William
Longhurst, Hilary
Katelaris, Constance H.
van Kooten, Sally
Heckmann, Markus
Malloy, Neil
Ulloa, Julie
Danese, Sherry
Magerl, Markus
-
Funding
Funding for this research was provided by:
KalVista Pharmaceuticals
- License Information
-
More Information
Article History
Received: 23 January 2025
Accepted: 1 May 2025
First Online: 21 May 2025
Declarations
:
: Prior to survey initiation, all materials were reviewed, and a waiver was granted by Advarra, an independent review board.
: All participants provided informed consent upon entry to the online survey for their data to be used anonymously or in aggregate prior to entering the survey.
: SDB: Consulting: KalVista Pharmaceuticals, Inc. JP: Educational/Research Grants: Takeda, Kalvista, Astria; honoraria: CSL Behring, Takeda; Meeting support: Sanofi, HAE International; Advisory Board participation: Pharvaris, Astria. WL: Consultant Arrangements: Astria, BioCryst, Biomarin, CSL Behring, Express Scripts/CVS, Fresenius Kabi, Intellia, Kalvista, Magellan, Optum, Pharming, Pharvaris, Shire/Takeda; Speakers’ Bureau: BioCryst, CSL Behring, Optinose, Pharming, Shire/Takeda, Grifols, Astra Zeneca, Sanofi/Regeneron, GSK; Current Grants/Research Support: Astria, BioMarin, CSL Behring, Grifols, Ionis, Kalvista, Shire/Takeda, Teva; Board Membership: US Hereditary Angioedema Association Medical Advisory Board, DFW Metroplex Allergy Society; Expert Witness: Vedder-Price: Henkel v. Reliastar and ESI, Murphy & King: Wellforce v. ANICO, Dorsey & Whitney: LGH v. Optu. HL: Research/ consultant and/or speaker for CSL Behring, Intellia, KalVista Pharmaceuticals, Inc., Pharvaris, Pharming, Takeda. CHK: Advisory Board participation for CSL Behring, Takeda, Biocryst, KalVista, Phavaris; honoraria for presentations from CSL Behring, Takeda; unrestricted research grant from CSL Behring; travel assistance from CSL Behring. SVK: Employment: KalVista Pharmaceuticals, Inc. MH: Employment: KalVista Pharmaceuticals, Inc. NM: Consulting: KalVista Pharmaceuticals, Inc. JU: Consulting: KalVista Pharmaceuticals, Inc. SD: Consulting: KalVista Pharmaceuticals, Inc. MM: Advisory Board participation, honoraria for presentations, or educational events for/from CSL Behring, Shire/Takeda, Pharming Technologies, BioCryst, Novartis, Octapharma, KalVista, Intellia, and Pharvaris.
